Similarly, knocking down EIF5A caused a significant decrease of CRC cell growth, and cell viability was no longer reduced by GC7 treatment in EIF5A-deficient cells (Fig. 1g). The gene discussed is EIF5A; the disease is colorectal carcinoma.